JP2015506347A5 - - Google Patents

Download PDF

Info

Publication number
JP2015506347A5
JP2015506347A5 JP2014548899A JP2014548899A JP2015506347A5 JP 2015506347 A5 JP2015506347 A5 JP 2015506347A5 JP 2014548899 A JP2014548899 A JP 2014548899A JP 2014548899 A JP2014548899 A JP 2014548899A JP 2015506347 A5 JP2015506347 A5 JP 2015506347A5
Authority
JP
Japan
Prior art keywords
optionally substituted
nitrogen
membered
oxygen
sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014548899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015506347A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/070980 external-priority patent/WO2013096637A1/en
Publication of JP2015506347A publication Critical patent/JP2015506347A/ja
Publication of JP2015506347A5 publication Critical patent/JP2015506347A5/ja
Pending legal-status Critical Current

Links

JP2014548899A 2011-12-23 2012-12-20 ヘテロアリールおよびその使用 Pending JP2015506347A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161579711P 2011-12-23 2011-12-23
US61/579,711 2011-12-23
US201261672030P 2012-07-16 2012-07-16
US61/672,030 2012-07-16
US201261716172P 2012-10-19 2012-10-19
US61/716,172 2012-10-19
PCT/US2012/070980 WO2013096637A1 (en) 2011-12-23 2012-12-20 Heteroaryls and uses thereof

Publications (2)

Publication Number Publication Date
JP2015506347A JP2015506347A (ja) 2015-03-02
JP2015506347A5 true JP2015506347A5 (enExample) 2016-02-18

Family

ID=48655164

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014548899A Pending JP2015506347A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用
JP2014548896A Pending JP2015503504A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用
JP2014548902A Pending JP2015503505A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014548896A Pending JP2015503504A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用
JP2014548902A Pending JP2015503505A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用

Country Status (7)

Country Link
US (3) US20130165472A1 (enExample)
EP (3) EP2793879A4 (enExample)
JP (3) JP2015506347A (enExample)
AR (3) AR089446A1 (enExample)
TW (3) TW201331194A (enExample)
UY (3) UY34539A (enExample)
WO (3) WO2013096642A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US9139589B2 (en) 2009-01-30 2015-09-22 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
MA34797B1 (fr) 2010-08-11 2014-01-02 Millennium Pharm Inc Hétéroaryles et leurs utilisations
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
EP2603216A4 (en) 2010-08-11 2013-12-18 Millennium Pharm Inc HETEROARYLE AND USES THEREOF
WO2012051410A2 (en) 2010-10-13 2012-04-19 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
AU2014312245B2 (en) 2013-08-28 2018-12-13 Medivation Technologies Llc Heterocyclic compounds and methods of use
WO2015108861A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2015108881A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2016050921A1 (en) * 2014-10-02 2016-04-07 F. Hoffmann-La Roche Ag Pyrazole carboxamide compounds for use in the treament of disorders mediated by bruton's tyrosine kinase (btk)
EP3265088A1 (en) 2015-03-04 2018-01-10 Medivation Technologies LLC Srebp blockers for use in treating liver fibrosis, elevated cholesterol and insulin resistance
US10189826B2 (en) 2015-03-04 2019-01-29 Medivation Technologies Llc Heterocyclic compounds and methods of use
JP2019513700A (ja) 2016-03-16 2019-05-30 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 殺有害生物剤及び植物保護剤としてのn−(シアノベンジル)−6−(シクロプロピル−カルボニルアミノ)−4−(フェニル)−ピリジン−2−カルボキサミド誘導体及び関連する化合物
EP3284739A1 (de) 2017-07-19 2018-02-21 Bayer CropScience Aktiengesellschaft Substituierte (het)arylverbindungen als schädlingsbekämpfungsmittel
IL271973B (en) 2017-07-28 2022-08-01 Yuhan Corp An improved process for the preparation of aminopyrimidine derivatives
JP7189932B2 (ja) 2017-07-28 2022-12-14 ユハン コーポレーション タンパク質キナーゼに対する選択的阻害剤の合成に有用な中間体及びそれを調製するためのプロセス
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN110041252A (zh) * 2019-05-22 2019-07-23 南京合巨药业有限公司 一种2-氯-4-肼基吡啶的制备方法
US12358905B2 (en) * 2019-05-31 2025-07-15 Bantam Pharamceutical, LLC Methods for making thiazolypyrazole carboxylic acids and intermediates therefor
WO2021011720A2 (en) * 2019-07-18 2021-01-21 Avidence Therapeutics, Inc. Anti-osteoarthritis compounds and related compositions and methods
TW202542143A (zh) * 2023-11-27 2025-11-01 美商魯貝多生命科學公司 碳連結bcl抑制劑及抗衰老化合物及其用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
MX9300141A (es) * 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
GB2306108A (en) * 1995-10-13 1997-04-30 Merck & Co Inc Treatment of Raf-mediated cancers with imidazole derivatives
WO1999032110A1 (en) * 1997-12-22 1999-07-01 Bayer Corporation INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
AU2002308748A1 (en) * 2001-05-16 2002-11-25 Vertex Pharmaceuticals Incorporated Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
AU2002355732B2 (en) * 2001-08-01 2006-11-09 Merck Sharp & Dohme Corp. Benzimidazo[4,5-f]isoquinolinone derivatives
US7582631B2 (en) * 2004-01-14 2009-09-01 Amgen Inc. Substituted heterocyclic compounds and methods of use
CN101084194A (zh) * 2004-12-21 2007-12-05 默克公司 有丝分裂驱动蛋白抑制剂
CA2594477C (en) * 2005-01-21 2016-07-12 Astex Therapeutics Limited Pharmaceutical compounds
CA2658764A1 (en) * 2006-07-20 2008-01-24 Mehmet Kahraman Benzothiophene inhibitors of rho kinase
UY30892A1 (es) * 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
US8338434B2 (en) * 2007-03-29 2012-12-25 Glaxosmithkline Llc Inhibitors of Akt activity
GB0709031D0 (en) * 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
US7928140B2 (en) * 2007-08-02 2011-04-19 Amgen Inc. Benzothiazole PI3 kinase modulators for cancer treatment
BRPI0908906A2 (pt) * 2008-03-21 2019-09-24 Novartis Ag compostos heterocíclicos e usos dos mesmos
BRPI0914223A2 (pt) * 2008-06-19 2019-09-24 Millennium Pharm Inc derivados de tiofeno ou tiazol e seus usos como inibidores de p13k
MX2010014572A (es) * 2008-06-27 2011-03-24 Novartis Ag Compuestos organicos.
US9139589B2 (en) * 2009-01-30 2015-09-22 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2010127152A2 (en) * 2009-04-29 2010-11-04 Irm Llc Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
EP2430013B1 (en) * 2009-05-13 2014-10-15 Amgen Inc. Heteroaryl compounds as pikk inhibitors
AR077975A1 (es) * 2009-08-28 2011-10-05 Irm Llc Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
EP2627650A2 (en) * 2010-05-26 2013-08-21 Merck Sharp & Dohme Corp. N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
WO2012084678A1 (en) * 2010-12-23 2012-06-28 Syngenta Participations Ag Novel imidazoles useful as plant fungicides
BR112013024122A2 (pt) * 2011-03-21 2019-09-24 Hoffmann La Roche compostos de benzoxazepina seletivos para p110 delta pi3k e métodos de uso
DK2794597T3 (en) * 2011-12-21 2018-01-15 Ono Pharmaceutical Co PYRIDINON AND PYRIMIDINON DERIVATIVES AS FACTOR XIA INHIBITORS

Similar Documents

Publication Publication Date Title
JP2015503505A5 (enExample)
JP2015503504A5 (enExample)
JP2011510080A5 (enExample)
JP6409004B2 (ja) ソルチリン阻害剤としてのn置換された5置換フタルアミド酸
TWI287004B (en) A pyridone derivative having an affinity effect for cannabinoid 2 type receptor
CA2563895C (en) Disalt inhibitors of il-12 production
TWI457337B (zh) 呋呫基苯并咪唑
JP2014512406A5 (enExample)
JP2008513508A5 (enExample)
JP2013533318A5 (enExample)
ES2824801T3 (es) Sal de compuesto heterocíclico sustituido con halógeno
KR20060123208A (ko) 피라진 유도체 및 이의 약학적 용도
WO2015069310A1 (en) Alkyl-amide-substituted pyridyl compounds useful as modulators of il-12, il-23 and/or ifnalpha responses
JP6666458B2 (ja) 置換のアミノ6員窒素含有複素環式化合物およびその製造と使用
AU2006267454A2 (en) Benzoimidazole compound capable of inhibiting prostaglandin D synthetase
JP2016508152A (ja) Cracチャネル阻害薬としての、ピラゾリルをベースとするカルボキサミド類i
WO2008152094A2 (en) Substituted acetamides as modulators of the ep2 receptor
JP2016513726A (ja) がん細胞成長阻害剤としてのテトラヒドロイソキノリン−2−イル−(キナゾリン−4−イル)メタノン化合物
US20100152240A1 (en) Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
CN104334528A (zh) (2-杂芳基氨基)琥珀酸衍生物
KR20150103752A (ko) Crac 채널 억제제로서의 피라졸릴계 카복스아미드 ⅱ
JP2008088107A (ja) 新規ピリダジン誘導体
JP6464244B2 (ja) Tert−ブチル n−[2−{4−[6−アミノ−5−(2,4−ジフルオロベンゾイル)−2−オキソピリジン−1(2h)−イル]−3,5−ジフルオロフェニル}エチル)−l−アラニネート又はその製薬上許容され得る塩、水和物もしくは溶媒和物
EP4017593B1 (en) Bicyclic agonists of stimulator of interferon genes sting
CN117466863A (zh) 含芳香族取代基的苯并咪唑化合物及其制备方法和用途